WHO ICTRP trial
Multicenter, randomized, prospective study to establish the clinical efficacy…
EUCTR2017-004983-37-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-004983-37-ES |
|---|---|
| Public title | Multicenter, randomized, prospective study to establish the clinical efficacy and the mechanisms of tolerance following immunosuppression withdrawal in liver transplantation |
| Scientific title | Multicenter, randomized, prospective study to establish the clinical efficacy and the mechanisms of tolerance following immunosuppression withdrawal in liver transplantation |
| Primary sponsor | Fundación para la Formación e Investigación Sanitarias de la Región de Murcia |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Spain |
| Conditions | Hepatic transplant;Therapeutic area: Body processes [G] - Immune system processes [G12] |
| Interventions | Trade Name: Sandimmun Neoral Product Name: Ciclosporin Product Code: NA Pharmaceutical Form: Capsule, soft INN or Proposed INN: CICLOSPORIN CAS Number: 59865-13-3 Current Sponsor code: FFIS-INM-2017-04 Other descriptive name: CICLOSPORIN… |
| Registration date | Jul 17, 2018 |
| Target size | 324 |
| Secondary IDs | FFIS-INM-2017-04 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: